Oxford Immunotec

This company says its tuberculosis screening product is quicker and more accurate than established methods, and its use helped sales reach £13.4m in 2012. Imperial Innovations and others have invested £18.2m in the University of Oxford spin-out, co-founded by chief executive Peter Wrighton-Smith, 39.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2013
Rank49
CompanyOxford Immunotec
ActivityMedical diagnostics provider
LocationAbingdon
Average 3 year sales growth69.63%
Latest sales £000s13,403
Staff131
Founded2002
Websitewww.oxfordimmunotec.com

If applicable:

* supplied by company † annualised figure